Interventions Required in AVFs versus AVGsInterventions Required in AVFs versus AVGs

Dallas—Increased placement of arteriovenous fistulas (AVF) has lead to increased non-maturing AVF requiring intervention prior to cannulation more frequently than arteriovenous grafts (AVG). That was one of the findings of a study conducted recently by James Harms, MD, and colleagues. Study results were reported during a poster session at the NKF Spring Clinical meetings in a poster titled Impact of ... Read More »

Urgent-Start PD Preferred Modality for Appropriate Candidates

Urgent-Start PD Preferred Modality for Appropriate Candidates Dallas—Results from a recent single-center prospective cohort study suggest that urgent-start peritoneal dialysis (PD) should be the preferred modality of dialysis offered to appropriate PD candidates who present unplanned requiring urgent dialysis. The study was conducted by Neda Hashemi, MD, and colleagues and reported during a poster session at the NKF Spring Clinical ... Read More »

Phosphorus Levels in Beverages Pose Risk for Kidney Disease Patients

Patients with kidney disease are at risk due to high levels of phosphorus levels in many beverages in the United States, according to a research letter published in the American Journal of Kidney Diseases and cited in an article in Medical News Today. Phosphorus levels are kept in balance by the kidneys, so those with kidney disease are at risk ... Read More »

Living in Poor Area Associated with Higher Rate of Kidney Disease

In a study reported in Hemodialysis International, researchers found that the association between poverty and kidney disease changes over time. According to an article in Medical News Today, Holly Kramer, MD, MPH, and colleagues reported that adults initiating kidney dialysis are more likely to be living in a zip code with high poverty rates compared with the general population. In ... Read More »

Cause of Kidney Failure Important in Treatment Decisions

In a study published recently in the Clinical Journal of the American Society of Nephrology, Michelle O’Shaughnessy, MD, and colleagues reported that treatment plans for patients with kidney failure should vary according to the root causes of the disease. “We showed that a patient’s cause of kidney failure is strongly associated with their risk of dying after starting dialysis or ... Read More »

Researchers Report Progress in Building Replacement Kidneys

In two recently reported studies, researchers at Wake Forest Baptist Medical Center report progress in their efforts to build replacement kidneys in the laboratory. In an article in Medical News Today, Giuseppe Orlando, MD, PhD, said, “We believe the two studies we are reporting provide critical information to the booming field of organ bioengineering as it applies to the kidney.” ... Read More »

NNCC Announces New Officers

In a recent press release, the Nephrology Nursing Certification Commission (NNCC) announced the appointment of two members to its Board of Commissioners. The NNCC is the certifying organization for nurses and technicians who care for nephrology patients. The new board members are Theresa Mottes, RN, CDN, of Cincinnati, Ohio, and Deborah Brooks, MSN, ANP-BC, CNN, CNN-NP, of Charleston, South Carolina. ... Read More »

Afinitor® as Second-Line Therapy for Advanced Renal Cell Carcinoma

During the 51st Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois, Novartis presented progression-free survival data supporting the efficacy of everolimus (Afinitor®) as second-line therapy in advanced renal cell carcinoma. The results from the phase 2 RECORD-4 (Renal Cell Cancer Treatment with Oral RAD001 Given Daily) study in 134 patients who had progressed on first-line treatment, ... Read More »

Nulojix® Demonstrates Relative Risk Reduction of Death of Graft Loss

Results from a 7-year, long-term follow-up from BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression Trial), a phase 3 prospective randomized trial of belatacept (Nulojix®) in kidney transplant patients were announced recently by Bristol-Myers Squibb Company. Belatacept demonstrated a statistically significant 43% relative risk reduction of death or graft loss in patients receiving an FDA-approved dosing regimen of ... Read More »


In his classic novel 1984 George Orwell used the term, doublethink, which he defined as “the power of holding two contradictory beliefs in one’s mind simultaneously, and accepting both of them.” While I greatly respect those at CMS who have the thankless task of writing rules and regulations, I had to chuckle when I came across a classic case of ... Read More »